University of Adelaide researchers recently announced they had made great strides in the development of a Zika virus vaccine, which could end up wiping out the disease permanently.
The Basil Hetzel Institute for Translational Health Research virology team, led by both Dr. Branka Grubor-Bauk and Prof. Eric Gowans, came up with a vaccine that stops the infection in pre-clinical models.
It’s the latest research, with years in development, that has been helped in its advancement thanks to funding from The Hospital Research Foundation and the National Foundation for Medical Research and Innovation.
There were several individuals who helped to work on the vaccine’s development:
- Harvard Medical School Center for Virology and Vaccine Research Director Prof. Dan Barouch
- University of Adelaide Robinson Research Institute Director Prof. Sarah Robertson
- University of Adelaide in Flinders and South Australia researchers
According to Dr. Grubor-Bauk, the team came up with a possible Zika vaccine using mouse models. The next thing for the team to do is ready the vaccine for a Phase 1 human clinical trial, which includes additional pre-clinical studies to learn what the most effective dosing is to protect humans from a Zika infection, Dr. Grubor-Bauk said.